The mouse TIK protein, a serine/threonine kinase, was originally isolated from a murine pre-B cell expression library by its ability to bind anti-phosphotyrosine antibodies (Icely et al., J. Biol. Chem. 266, 16073 -16077,1991). The 67 kDa protein was found to have an associated autophosphorylation activity when incubated with ATP. Our results show that TIK is actually the mouse interferon-induced, dsRNAdependent protein kinase, PKR. We demonstrate that the TIK message is interferon-inducible in mouse Lcells and in vitro transcription and translation of the TIK cDNA produces a protein that is capable of binding double-stranded RNA. The in vitro synthesized TIK protein migrated as a 65 kDa protein on SDS-PAGE when incubated with ATP, but migrated as a 60 kDa protein when incubated with an inhibitor of PKR, 2-aminopurine. We further show that proteolytic digestion of TIK with Staphylococcus aureus V8 protease results in a cleavage pattern identical to that obtained by V8 digestion of authentic PKR. Antiserum to TIK specifically recognized PKR. Cloned TIK had inhibitory activity for replication of EMCV but not VSV. From these observations we conclude that TIK kinase is the mouse interferon-induced, double-stranded RNAdependent kinase, PKR.
INTRODUCTION
The dsRNA-dependent protein kinase, PKR, is an IFN-inducible protein involved in the inhibition of protein synthesis. This kinase, also known as the P^eEF^a protein kinase, p65 (mouse and rabbit) or p68 (human) kinase, DAI and dsl (2) (3) (4) (5) (6) , plays a key role in the antiviral action of IFN against several animal viruses (5,7). The dsRNA-dependent protein kinase is synthesized in an inactive form and becomes activated by interacting with dsRNA (8) . Activation involves autophosphorylation of the enzyme (9) . Incorporation of phosphate leads to a shift in electrophoretic mobility of the activated mouse kinase by SDS-PAGE, from a M r of approximately 60,000 for the inactive mouse kinase to a M r of approximately 65,000 for activated mouse kinase (9) .
Kinase autophosphorylation and, therefore, activation can be blocked by 2-aminopurine (10) (11) (12) . In its active form, PKR can phosphorylate exogenous substrates including the a subunit of the eukaryotic translation initiation factor eIF-2 (13, 14) . Phosphorylation of eIF-2a inhibits protein synthesis at the initiation step of translation (15) (16) (17) . The dsRNA-dependent protein kinase may also phosphorylate other IFN-regulating proteins such as the nuclear transcription factor NFxB (18) . NFxB can be activated by dsRNA via the phosphorylation and release of its inhibitor IxB (19, 20) . It is possible that the dsRNAdependent protein kinase may be involved in this activation, or possibly the phosphorylation of other IFN-regulated proteins.
A cDNA clone of the human dsRNA-dependent protein kinase has been isolated (2, 3) . The human PKR mRNA is induced by IFN-a and produces a protein product of 68 kDa, p68. The deduced amino acid sequence from the human PKR cDNA predicts a protein which contains all of the conserved motifs characteristic of serine/threonine protein kinases (21) . The human PKR cDNA was recently used as a probe to screen a mouse cDNA library under low stringency conditions (22) . A clone was identified with a predicted amino acid sequence 61 % identical to the human kinase. Based on this homology, Feng et al. speculated that this cDNA encoded the mouse dsRNA-dependent protein kinase (22) , and noted that the cDNA sequence was nearly identical to the mouse TIK sequence (1) .
Mouse TIK, a serine/threonine kinase, was originally isolated from a murine pre-B cell expression library by its ability to bind anti-phosphotyrosine antibodies (1) . In vitro transcription and translation of the cloned TIK cDNA produced a polypeptide of approximately 67 kDa, significantly larger than the predicted molecular mass of the protein (58.5 kDa) (1). The 67 kDa protein was found to have an associated autophosphorylation activity when incubated with ATP (1). Given the sequence similarity to the human dsRNA-dependent protein kinase and the apparent and predicted M r of TIK, we and others speculated that TIK might be the mouse dsRNA-dependent protein kinase (2, 22) . Alternatively, these two proteins could represent different members of a kinase gene family. To determine if TIK is the mouse dsRNA-dependent protein kinase, we have compared the biochemical characteristics of TK to the known properties of the dsRNA-dependent protein kinase. We have determined that TIK mRNA is IFN inducible in mouse L-cells. Furthermore, we demonstrate that an in vitro translation product of the TIK mRNA bound dsRNA-and poly(rI)-poly(rC)-sepharose. The in vitro synthesized TIK protein migrated as a 65 kDa protein on SDS-PAGE after incubation with ATP, but migrated as a 60 kDa protein after incubation with a dsRNA-dependent protein kinase inhibitor, 2-aminopurine. We further show that proteolytic digestion of TIK with Staphylococcus aureus V8 protease results in a cleavage pattern identical to that obtained by V8 digestion of authentic mouse dsRNA-dependent protein kinase. Antiserum to recombinant TIK protein specifically recognized an EFNinducible protein in crude L-cell extracts that co-migrated with authentic PKR and had a peptide map indistinguishable from authentic PKR. Finally, the cloned TIK gene had anti-viral properties similar to human PKR (23) . These results demonstrate that TIK cDNA actually encodes the mouse interferon-induced dsRNA-dependent protein kinase, PKR.
MATERIALS AND METHODS
Production of mouse TIK cDNA, cloning, sequencing, and expression of the TIK gene Mouse L-cells were maintained in suspension in Eagle's suspension minimal essential media MEM (Gibco) supplemented with 5% fetal bovine serum (HyClone Laboratories), 50 /ig of gentamicin/ml, 100 fig of glucose/ml, 292 ng of L-glutamine/ml, 110 fig of sodium pyruvate/ml, and 0.1 mM nonessential amino acids. Cells, at a density of 1 x 10 6 cells/ml, were treated with mouse IFN-/3 (Lee Biochemical, 1.3 xlO 8 IU/mg) at 500 units/ml for 12 hours. L-cell mRNA was purified using Fast Track mRNA Isolation Kit (Invitrogen). cDNA was prepared from L-cell mRNA (0. (identical to nucleotides 1091 -1110 in the coding sequence of the TIK gene), additional TIK reverse primer and 2 units of Taq polymerase (Perkin Elmer) were added to one half of the diluted cDNA reaction mixture. PCR cycles were 94°C for 1 minute, 50° C for 2 minutes, 72° C for 4 minutes, for 25 cycles. An approximately 650 base pair fragment, corresponding to the back 1/3 of the gene, was isolated, cut with Pst I and EcoR I and cloned into Pst I and EcoR I cut pBluescript. The front 2/3 of the gene was amplified from the cDNA reaction mixtures as described above using an oligonucleotide (TTK forward) with sequence 5' CGACCCGGGAAAAATGGCCAGTGAT 3' (identical to nucleotides 136-153 of the TIK gene and containing a Sma I restriction site) and an oligonucleotide (TIK front reverse) with sequence 5' TTATCACAGAATTCCAT 3' (identical to nucleotides 1120-1140 of the TK sequence). The amplified DNA of approximately 1 kbp was cut with Sma I and EcoR I, and cloned into Sma I and EcoR I cut pBluescript. To reassemble the full length gene, the front fragment of TK was isolated after digestion of the plasmid with EcoR I and Sma I. Gel purified fragment was cloned into Hinc U and EcoR I cut plasmid containing the back fragment of TK, downstream from the bacteriophage T3 promoter. The plasmid was designated pBS-TK. The cDNA insert was sequenced using Sequenase (United States Biochemical) according to the manufacturer's protocol. For in vitro transcription of the TDC cDNA, the plasmid was linearized and treated with proteinase K (50 /ig/ml) for 30 minutes at 37°C. The DNA was extracted with phenol/chloroform and isolated by centrifugation following ethanol precipitation. 
Preparation of antiserum to recombinant TTK
The bacterial strain XL-1 Blue was transformed with plasmid pBS-TK. Cells were grown in Luria Broth containing 50 /ig/ml ampicillin. When cells reached a density of 00600=0. 
Preparation of mouse dsRNA-activated kinase
Protein extracts containing mouse dsRNA-dependent protein kinase were prepared from L-cells treated with 100 units/ml of recombinant human IFN-a A/D for 18 hours. The dsRNAdependent protein kinase was partially purified from the RSW fraction of these cells as previously described (23) . The RSW fraction was incubated with poly(rl) • poly(rC)-sepharose for 1 hour at 4° C. Proteins bound to resin were washed 3 x with buffer A (20 mM HEPES, pH 7.5; 50 mM KC1; 5 mM MgOAc; 1 mM DTT; 1 mM Benzamidine; 10% glycerol). The poly(rI)-poly(rC) bound proteins were further incubated with buffer A containing [7 32 P]ATP (3 X 10~2 /M) for 15 minutes at 30°C. Proteins were denatured in SDS solubilization buffer and separated by SDS-PAGE. Activated mouse dsRNAdependent protein kinase was visualized by autoradiography.
Binding of mouse TTK protein to poly(rl) • poly(rC)-sepharose
Mouse TIK cDNA was transcribed in vitro, and the resulting products were translated in a rabbit reticulocyte system. The protein products were analyzed by affinity chromatography to determine their ability to bind poly(rl) • poly(rC)-agarose. For each binding, 35 ^1 of translation reaction was incubated with an equal volume of poly(rl) • poly(rC)-sepharose for 1 hour at 4° C. The bound proteins were washed 3x with buffer A. Where indicated, samples were then incubated in 20 fd Buffer A containing 100 /tM ATP for 15 minutes at 30°C.
Staphylococcus aureus V8 protease peptide mapping
Peptide mapping was performed as previously described (24, 25) . Briefly, [
35 S]methionine-labeled in vitro translated TIK protein or [7 32 P]ATP-phosphorylated RSW kinase were separated by SDS-PAGE, stained briefly in Coomassie Brilliant Blue R-250, and destained in methanol/acetic acid. The 65 kDa bands were cut from the gel and equilibrated in buffer (125 mM Tris, pH 6.8; 0.1% SDS; 1 mM EDTA; 1 mM dithiothreitol) for 20 minutes at 25 °C. The gel fragments containing the 65 KDa proteins were then placed into the wells on a second 12% SDS polyacrylamide gel and overlaid with sample buffer containing 10% v/v glycerol and 25 ng of V8 protease (Boehringer Mannheim). The protein samples were electrophoresed through the stacking gel at 30 mA. Electrophoresis was stopped, and V8 protease digestion was allowed to occur for 30 minutes. Electrophoresis was then continued through the resolving gel. Protein fragments were visualized by Coomassie staining and autoradiography.
Expression of TIK in HeLa cells
The TK gene was subcloned from pBS-TIK into pMTVa-. pBS-TIK was cleaved with Kpn I, and ends were blunted with T4 DNA polymerase. Linearized blunted pBS-TIK was cleaved with Sma I and the 1.7 kbp fragment was gel purified and cloned into EcoR I cut, blunted (T4 DNA polymerase), phosphatase-treated pMTVa-. Orientation was determined by cleavage with Pst I. A clone with the TIK gene oriented downstream from the adenovirus major late promoter was designated pMT-TIK. pMT-TIK, purified with a Qiagen Plasmid Kit according to the manufacturers instructions, was transfected into HeLa cells by a modification of the calcium phosphate precipitation technique (26, 27) . Briefly, 20 /tg of pMT-TTK in 500 /tl of 250 mM CaCl 2 was added dropwise to an equal volume of 2xHBS, pH 7.05, while continually applying a gentle airstream to the surface of the 2xHBS. After allowing the mixture to stand undisturbed for 10-20 min, the solution was layered under the surface of the growdi medium (DMEM (Gibco), containing 10% fetal bovine serum (HyClone Laboratories), and 50 /tg of gentamicin/ ml) covering a just confluent monolayer of HeLa cells. After 8 hours the medium was removed from the monolayer and the cells were washed three-times with complete medium. Twelve hours later cells were infected with either EMCV or VSV at an MOI of 5 pfu/cell. After 18 hours progeny virus was harvested and assayed by plaque formation onto monolayers of HeLa cells. (Figure 1, lanes 1 and 8) . Therefore, we estimate that IFN-treated L-cells contain approximately 20 fold higher levels of TK mRNA than untreated cells.
RESULTS

The TIK message is induced by interferon
Cloning, expression, and sequencing of the mouse TIK gene Oligonucleotide primers specific for non-translated regions 5' and 3' to the coding region of the published TIK sequence and overlapping internal primers (1) were synthesized. 5' and 3' fragments of mouse TIK cDNA were amplified from total L cell cDNA by PCR. The TIK cDNA was reconstructed in pBluescript downstream from the bacteriophage T3 promoter. In vitro transcription and translation of the TIK clone in a cell free rabbit reticulocyte system produced several protein products in the 55-65 kDa range (Figure 2, lane 1) .
Comparison of our PCR amplified TTX sequence to the published TIK sequence identified several nucleotide discrepancies which would affect, most notably, the translation stop site as well as two amino acid in the putative dsRNA binding domain of the protein. The sequence we amplified using PCR primers to the TIK non-translated region was identical to the cDNA obtained by Feng et al. (22) .
TIK protein binds dsRNA and 'shifts' in apparent molecular weight when incubated with ATP
The products obtained by in vitro translation of TK mRNA were incubated with poly(rl) -poly(rC)-sepharose to determine whether any of the newly synthesized proteins could bind to dsRNA. Two proteins bound specifically to poly(rl) • poly(rC)-sepharose, but did not bind to the sepharose resin alone (Figure 2, lanes 2-3) . The higher molecular weight protein (approximately 65 kDa) was more abundant than the lower molecular weight protein (approximately 60 kDa). These proteins most likely correspond to the non-phosphorylated and phosphorylated forms of mouse dsRNA-dependent protein kinase. Since the rabbit reticulocyte translation mix contains ATP, it is likely that the mouse kinase would become phosphorylated when bound to poly(rI)poly(rC)-sepharose, and therefore migrated as a 65 kDa protein through SDS-PAGE.
To determine if the higher molecular weight protein (p65) actually represents a phosphorylated form of the lower molecular weight protein, 5 mM of the PKR inhibitor 2-aminopurine was added at the time of translation. Translation and binding in the presence of 2-aminopurine resulted in visualization of only the lower molecular weight protein (p60) (Figure 3, lane 1) . None of the higher molecular weight species was detected. Washing of the bound protein to remove the 2-aminopurine, and addition of exogenous ATP resulted in the protein now migrating as the higher molecular weight form on SDS-PAGE ( Figure 3, lane 2) .
In vitro synthesized TIK protein has a V8 proteolysis pattern similar to authentic dsRNA-dependent protein kinase Mouse dsRNA-dependent protein kinase, when digested with Staphylococcus aureus V8 protease, has previously been shown to migrate as three peptides by SDS-PAGE (24) . The two larger fragments migrate as a doublet of 38-40 kDa, while the third peptide migrates as a smaller fragment of 26 kDa. The in vitro synthesized mouse TIK protein (Figure 4, lane 1) gave an identical V8 map to activated ribosomal salt wash purified kinase ( Figure 4, lane 2) . The upper doublet of both the TIK and RSW kinase migrated at approximately 38-40 kDa; whereas, the lower fragments migrated at approximately 26 kDa.
Antiserum to recombinant TIK protein recognizes the dsRNA-dependent mouse kinase Antiserum produced against a /3-galactosidase-TTK fusion protein produced in E.coli specifically recognized the dsRNA-dependent mouse kinase in crude L-cell extracts. Western blot analysis demonstrated that the antiserum, at a dilution of 1:1000, recognized a protein of 65 kDa in crude extracts from IFN-treated L-cells that had been incubated with poly(rI).poly(rC) sepharose and [y 32 P]ATP, but only weakly detected the protein in identically prepared extracts from untreated L-cells ( Figure 5A ). Autoradiography of the Western blot confirmed that the antiserum specifically recognized a protein that migrates identical to the radiolabeled mouse dsRNA-dependent protein kinase (data not shown). In extracts from IFN-treated cells, the antibody recognized both the non-phosphorylated and phosphorylated forms of this protein. In addition, the three proteolytic fragments obtained by V8 digestion of L-cell purified dsRNA-dependent protein kinase were also recognized by antiserum to TIK ( Figure 5B ).
Inhibition of virus replication by cloned TTK
Cloned human PKR has been reported to inhibit replication of EMCV but not VSV (23) To determine if mouse TTK had similar properties we have subcloned the mouse TIK gene into a eukaryotic expression vector pMTVa-(pMT-TTK). Either parental plasmid (pMTVa-) or plasmid expressing TK (pMT-TTK) was transfected into HeLa cells using a technique that allows expression of transfected DNA in a high percentage of cells (26, 27) . Transfected monolayers were subsequently infected with either VSV or EMCV, and progeny virus was quantitated after a single cycle of virus infection. As can be seen in Figure 6 , expression of pMTVa -had little effect on replication of EMCV or VSV (data not shown) compared to mock transfected cells. However, constitutive expression of TIK inhibited EMCV replication approximately 10-fold. Expression of TIK had little effect on VSV replication. These results suggest that mouse TTK has an anti-viral activity similar to human PKR.
DISCUSSION
Previous work (22) has identified a mouse cDNA, nearly identical in sequence to TIK (1) , that shares 61 % homology at the amino acid level with the human dsRNA-dependent protein kinase, PKR (3). The results presented in this paper demonstrate that this mouse cDNA (Genebank accession no. M93567) represents the correct sequence for TTK (Genebank accession no. M6529) and that TIK encodes a protein that exhibits properties identical to murine PKR. IFN-/3) . The predicted and actual molecular weights of the TTK protein also correspond to the molecular weights of the phosphorylated and nonphosphorylated forms of the dsRNA-dependent protein kinase. The TTK cDNA sequence predicts a protein of 60 kDa. When incubated with ATP and dsRNA, however, products of TTK primed translation migrated on SDS-PAGE as a larger species (65 kDa). This shift in molecular weight was inhibited by 2-aminopurine, an inhibitor of PKR. Similarly, the cDNA sequence of human PKR predicts a protein of 62 kDa, yet authentic human PKR migrates as a 67-68 kDa protein (2) . Cleavage of in vitro transcribed TTK by V8 protease produced three fragments which were identical in size to the three fragments obtained by digestion of purified mouse PKR with V8 protease.
Antiserum produced against recombinant TIK protein specifically recognized both the nonphosphorylated and phosphorylated forms of the dsRNA-dependent mouse kinase in crude extracts, as well as the three proteolytic fragments of PKR obtained by V8 digestion. Finally, the mouse UK gene had an anti-viral activity similar to the human PKR, in that expression of TIK inhibited EMCV but not VSV replication.
In addition to homology with the human dsRNA-dependent protein kinase (3, 22) TIK further shares N-terminal homology with several other dsRNA-binding proteins, such as vaccinia virus E3L (28), rotavirus NS34 (29), the tar/RRE binding protein (30, 31) , and E.coli RNase HI (32) . This region has been shown to be necessary for dsRNA binding of the human dsRNAdependent protein kinase (22, 3) and for the vaccinia virus E3L-encoded proteins (34) . Mouse PKR also contains eleven catalytic domains (21) and a striking nine amino acid region of homology which has been suggested to be involved in eIF-2 recognition (35) . The mouse dsRNA-dependent protein kinase sequence further contains the kinase recognition sequence for cdc2 phosphorylation (Ser/Thr-Pro-X-Arg/Lys) at residues 162-166, specifically Lys-Ser-Pro-Pro-Lys. (36) . This kinase recognition sequence is not conserved at the comparable region of the human dsRNA-dependent protein kinase, however, a similar sequence (Lys-Ser-Pro-Glu-Lys) is found C-terminal of the XI catalytic domain (3) of human dsRNA-dependent protein kinase.
It is interesting to note that the TIK cDNA was initially isolated by screening a Xgtl 1 expression library with anti-phosphotyrosine antibodies, and to note that in vitro transcribed and translated TIK protein can be detected and immunoprecipitated with three different monoclonal anti-phosphotyrosine antibodies and a polyclonal anti-phosphotyrosine antibody (1). Yet, TIK lacks phosphotyrosyl residues, and under no conditions has this kinase been found to posses a tyrosine phosphorylating ability. It has been suggested that the primary sequence of TIK encodes an epitope resembling phosphotyrosine, and this epitope may represent a binding site for molecules which specifically recognize phosphotyrosyl residues (1) . If this is true, the dsRNA-dependent protein kinase may have a yet undefined role in signal transduction and/or cell cycle control.
Transphosphorylation of growth factor receptor tyrosine kinases requires dimerization of the receptor for subsequent signal transduction (37) , and mutations in the catalytic sites of receptor tyrosine kinases have dominant negative effects (38) . The dsRNAdependent protein kinase also undergoes dimerization that is phosphorylation-dependent (24) and mutation of the putative eEF-2 recognition region, conserved between the mouse, human and yeast proteins, results in a dominant negative effect on autophosphorylation of this kinase (39) . Furthermore, expression of the mutant human dsRNA-protein kinase in NIH 3T3 cells results in transformation of these cells (39) , whereas wild type human dsRNA-dependent protein kinase has an inhibitory effect on cell growth (40) . Evidence that the human dsRNA-dependent protein kinase may function as a suppressor of cell proliferation and tumorigenesis supports the idea that this protein may share a related function to tyrosine kinases in controlling signal transduction and cell growth.
Note added in proof
While this work was in progress Patel and Sen (/. Interferon Research 12, 389-393, 1992 ) published work demonstrating that carboxy-terminal TIK domains were functionally equivalent to human PKR domains.
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